Compare OABI & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OABI | TRNS |
|---|---|---|
| Founded | 2012 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 773.1M | 807.1M |
| IPO Year | 2021 | 1995 |
| Metric | OABI | TRNS |
|---|---|---|
| Price | $4.66 | $93.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $8.33 | ★ $110.80 |
| AVG Volume (30 Days) | ★ 1.3M | 161.2K |
| Earning Date | 10-30-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.56 | N/A |
| EPS | N/A | ★ 0.40 |
| Revenue | $18,666,000.00 | ★ $331,877,000.00 |
| Revenue This Year | $94.10 | $21.36 |
| Revenue Next Year | $30.33 | N/A |
| P/E Ratio | ★ N/A | $244.15 |
| Revenue Growth | N/A | ★ 19.20 |
| 52 Week Low | $1.35 | $50.23 |
| 52 Week High | $5.45 | $112.44 |
| Indicator | OABI | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 42.52 | 46.79 |
| Support Level | $4.53 | $81.80 |
| Resistance Level | $5.43 | $100.00 |
| Average True Range (ATR) | 0.32 | 4.65 |
| MACD | -0.05 | -0.95 |
| Stochastic Oscillator | 4.76 | 20.20 |
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.